Skip to main content
. 2021 Feb 10;12:631845. doi: 10.3389/fmicb.2021.631845

TABLE 1.

Summary of the 47 ST59 isolates selected for whole genome sequencing.

IEC
MES
WGS Strain MRSA/ Year Location PFGE spa SCC PVL scn chp sak sea sep ϕSa3 IEC IS1216V tnp tnpR ermB aph sat aadE IS1216V cat IS1216V aacA- MES C. elegans
subgroup MSSA group mec Integrase Type tn551 (3′)-III aphD Type calibrated death
1 H509 MSSA 1993 CAN 1 172 + + + + C* 0.4017
S2459 MSSA 2010 CAN 6 163 + + + + C* 0.2460
H291 MRSA 1992 CAN 6 163 IV + + + + C* 0.5103
PRE MSSA 2001 CAN 6 163 + + + + C* 0.1724
GD321 MSSA 2010 GD 6 163 + + + + + B* 0.2371
2 SSR MSSA 2012 CAN 6 216 + + C 0.4333
KAE MSSA 2007 CAN 6 2365 + + C 0.1000
290N MSSA 2014 CAN 6 216 + + C 0.1517
3 GD1409 MRSA 2010 GD 3 437 IVg + + + + G + + + + + + + + + unk-1 0.1067
GD875 MSSA 2010 GD 3 1751 + + + + G + + + + + + + + + unk-1 0.1265
4 GD912 MRSA 2010 GD 4 437 IVa + + + + B + + + + + + + + + PM9 0.0000
GD517 MRSA 2010 GD 6 437 IVa + + + + B + PM18 0.2111
GD26 MRSA 2010 GD 1 437 IVa + + + + B + PM18 0.2782
GD38 MRSA 2010 GD 3 437 IVa + + + + B + + + + + + + PM9 0.1522
GD31 MRSA 2010 GD 3 441 IVa + + + + B + + + + + + + + + PM9 0.0000
GD3.1 MRSA 2010 GD 5 441 IVa + + + + B + + + + + + + + + PM9 0.1211
GD1633 MRSA 2010 GD 2 441 IVa + + + + C** + + + + + + + + + PM9 0.0278
GD75 MRSA 2010 GD 3 437 IVa + + + + B + + + + + + + + + PM9 0.0692
GD19 MRSA 2010 GD 5 437 IVa + + + + B + + + + + + + + + PM9 0.1703
GD81 MRSA 2010 GD 3 437 IVa + + + + B + + + + + + + + + PM9 0.0775
GD15 MRSA 2010 GD 3 437 IVa + + + + B + + + + + + + + + PM9 0.1827
GD1907 MRSA 2010 GD 3 437 IVa + + + + B + + + + + + + + + PM9 0.0324
GD1958 MRSA 2010 GD 1 437 IVa + + + + B + + + + + + + + + PM9 0.1479
5 SA28 MSSA 2003 CAN 2 437 + + + C + + + + + + + + + PM9 0.2010
GD52 MRSA 2010 GD 2 437 IVa + + + C + + + + + + + + + PM9 0.0702
GD858 MRSA 2010 GD 2 4347 IVa + + + C + + + + + + + + + PM9 0.3086
GD1054 MRSA 2010 GD 5 437 IVa + + + + + C* + + + + + + + + + PM9 0.1360
GD27 MRSA 2010 GD 4 441 IVa + + + + + C* + + + + + + + + + PM9 0.2447
GD1605 MSSA 2010 GD 1 1751 + + C + + + + + + + + + + PM1 0.3899
GD251 MSSA 2010 GD 5 3485 + + C + + + + + + + + + + PM1 0.0604
GD1171 MSSA 2010 GD 5 8886 + + C + + + + + + + + + + PM1 0.5861
GD843 MSSA 2010 GD 1 8886 + + C + PM18 0.2307
GD1941 MRSA 2010 GD 5 437 IVa + + C + + + + + + + + + + PM1 0.1778
GD910 MSSA 2010 GD 5 4134 + + C + PM18 0.0000
GD1976 MRSA 2010 GD 5 437 IV + + C + + + + + + + PM9 0.0333
GD511 MSSA 2010 GD 2 437 + + + C + + + + + + + + + PM9 0.2046
IEC MES
GD1176 MSSA 2010 GD 7 437 + + C + PM18 0.0707
GD1038 MRSA 2010 GD 3 437 IVg + + C + + + + + + + + + + PM1 0.1000
GD954 MSSA 2010 GD 7 437 + + C + + + + + + + + PM9 0.0679
6 MS07MS-625 MRSA 2007 CAN 2 437 Vb + + + C + + + + + + + + + PM9 0.2371
CAN20 MRSA MAL 2 3590 Vb + + + C + + + + + + + + + PM9 0.0693
C11224 MRSA 2006 CAN 2 437 Vb + + + C + + + + + + + + + + PM1 0.0636
C3714 MRSA 2006 CAN 2 unk Vb + + + C + + + + + + + + + + PM1 0.4278
GD21 MRSA 2010 GD 2 437 Vb + + + C + + + + + + + + + + PM1 0.0000
GD1068 MRSA 2010 GD 7 437 Vb + + C + + + + + + + + + + PM1 0.1269
GD1199 MRSA 2010 GD 2 437 Vb + + + C + + + + + + + + + + PM1 0.1037
C889b MRSA 2008 CAN 2 437 Vb + + + C + + + + + + + + + + PM1 0.2376

Country and year of isolation are indicated, as well as relevant molecular characteristics and their associated virulence, as measured in the C. elegans infection model. MRSA, methicillin resistant Staphylococcus aureus; MSSA, methicillin sensitive Staphylococcus aureus; PFGE, Pulsed field gel electrophoresis; spa, staphylococcal protein A; SCCmec, Staphylococcal cassette chromosome mec; PVL, Panton-Valentine leucocidin; IEC, immune evasion cluster; scn, complement inhibitor; chp, chemotaxis-inhibiting protein; sak, Staphylokinase precursor; sea, staphylococcal enterotoxin A precursor; sep, staphylococcal enterotoxin P precursor; MES, mobile element structure; tnp tn551, tn551 transposase; tnpR, resolvase; ermB, erythromycin resistance transferase; aph(3′)-III, aminoglycoside 3′-phosphotransferase; sat, streptothricin acetyltransferase; aadE, streptomycin adenylyltransferase; cat, chloramphenicol acetyltransferase; aacA-aphD, bifunctional aminoglycoside modifying enzyme; , as defined by Hung et al. (2016) and this study; , as defined by Hung et al. (2012) and this study; +, positive for trait/gene; −, negative for trait/gene; * and **, IEC variants as defined by Table 2 of this study; unk, unknown.